LSU Health New Orleans to receive patent for a noninvasive test to diagnose fatal condition in preemies

Group of the scientists working at the laboratory

US Patent 11,493,515 will be issued to LSU Health New Orleans on November 8, 2022, for a noninvasive test that more accurately diagnoses a potentially fatal condition in premature infants.

Ready to shop? These are the best Walmart Black Friday deals you can buy right now.

Previous article

Study helps to justify the use of Ayres Sensory Integration as a tool for autistic children

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in News